These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38539027)

  • 21. Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progression.
    Lennie JL; Mondick JT; Gastonguay MR
    J Pharmacokinet Pharmacodyn; 2020 Feb; 47(1):91-104. PubMed ID: 31960231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of Ankle Plantarflexion Contractures and Functional Decline in Duchenne Muscular Dystrophy: Implications for Physical Therapy Management.
    Kiefer M; Bonarrigo K; Quatman-Yates C; Fowler A; Horn PS; Wong BL
    Pediatr Phys Ther; 2019 Jan; 31(1):61-66. PubMed ID: 30557283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.
    Ayyar Gupta V; Pitchforth JM; Domingos J; Ridout D; Iodice M; Rye C; Chesshyre M; Wolfe A; Selby V; Mayhew A; Mazzone ES; Ricotti V; Hogrel JY; Niks EH; de Groot I; Servais L; Straub V; Mercuri E; Manzur AY; Muntoni F;
    PLoS One; 2023; 18(4):e0283669. PubMed ID: 37099511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial.
    Mendell JR; Sahenk Z; Lehman K; Nease C; Lowes LP; Miller NF; Iammarino MA; Alfano LN; Nicholl A; Al-Zaidy S; Lewis S; Church K; Shell R; Cripe LH; Potter RA; Griffin DA; Pozsgai E; Dugar A; Hogan M; Rodino-Klapac LR
    JAMA Neurol; 2020 Sep; 77(9):1122-1131. PubMed ID: 32539076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys.
    Stimpson G; Ridout D; Wolfe A; Milev E; O'Reilly E; Manzur A; Sarkozy A; Muntoni F; Cole TJ; Baranello G;
    J Neuromuscul Dis; 2024; 11(1):153-166. PubMed ID: 37980680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.
    Schiava M; McDermott MP; Broomfield J; Abrams KR; Mayhew AG; McDonald CM; Martens WB; Gregory SJ; Griggs RC; Guglieri M;
    Neurology; 2024 May; 102(10):e209206. PubMed ID: 38710006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.
    Bello L; Campadello P; Barp A; Fanin M; Semplicini C; Sorarù G; Caumo L; Calore C; Angelini C; Pegoraro E
    Sci Rep; 2016 Sep; 6():32439. PubMed ID: 27582364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.
    Lerario A; Bonfiglio S; Sormani M; Tettamanti A; Marktel S; Napolitano S; Previtali S; Scarlato M; Natali-Sora M; Mercuri E; Bresolin N; Mongini T; Comi G; Gatti R; Ciceri F; Cossu G; Torrente Y
    BMC Neurol; 2012 Sep; 12():91. PubMed ID: 22974002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.
    Muntoni F; Guglieri M; Mah JK; Wagner KR; Brandsema JF; Butterfield RJ; McDonald CM; Mayhew AG; Palmer JP; Marraffino S; Charnas L; Mercuri E
    PLoS One; 2022; 17(8):e0272858. PubMed ID: 35998119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gait classification for growing children with Duchenne muscular dystrophy.
    Vandekerckhove I; Papageorgiou E; Hanssen B; De Beukelaer N; Van den Hauwe M; Goemans N; Van Campenhout A; De Waele L; De Groote F; Desloovere K
    Sci Rep; 2024 May; 14(1):10828. PubMed ID: 38734731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal natural history in young boys with Duchenne muscular dystrophy.
    Coratti G; Brogna C; Norcia G; Ricotti V; Abbott L; D'Amico A; Berardinelli A; Vita GL; Lucibello S; Messina S; Sansone V; Albamonte E; Colia G; Salmin F; Gardani A; Manzur A; Main M; Baranello G; Arnoldi MT; Parsons J; Carry T; Connolly AM; Bertini E; Muntoni F; Pane M; Mercuri E
    Neuromuscul Disord; 2019 Nov; 29(11):857-862. PubMed ID: 31629611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle MRI and functional outcome measures in Becker muscular dystrophy.
    Barp A; Bello L; Caumo L; Campadello P; Semplicini C; Lazzarotto A; Sorarù G; Calore C; Rampado A; Motta R; Stramare R; Pegoraro E
    Sci Rep; 2017 Nov; 7(1):16060. PubMed ID: 29167533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance.
    Oreto L; Vita GL; Mandraffino G; Carerj S; Calabrò MP; Manganaro R; Cusmà-Piccione M; Todaro MC; Sframeli M; Cinquegrani M; Toscano A; Vita G; Messina S; Zito C
    Acta Myol; 2020 Dec; 39(4):191-199. PubMed ID: 33458574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study.
    Muntoni F; Signorovitch J; Sajeev G; Done N; Yao Z; Goemans N; McDonald C; Mercuri E; Niks EH; Wong B; Vandenborne K; Straub V; de Groot IJM; Tian C; Manzur A; Dieye I; Lane H; Ward SJ; Servais L; ; ; ; ;
    PLoS One; 2024; 19(7):e0304984. PubMed ID: 38985784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy.
    Rabbia M; Guridi Ormazabal M; Staunton H; Veenstra K; Eggenspieler D; Annoussamy M; Servais L; Strijbos P
    J Neuromuscul Dis; 2024; 11(3):701-714. PubMed ID: 38640165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy.
    Li X; Lv J; Zhu W; Hong S; Wang Z; Chang X; Gao YX; Zhou Y; Jia C; Fang J; Patterson TA
    Lancet Reg Health West Pac; 2024 Jan; 42():100944. PubMed ID: 38089167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.